Fortress Biotech, Inc.
FBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $18 | $16 | $13 | $15 |
| % Growth | 7.4% | 24.9% | -13.1% | – |
| Cost of Goods Sold | $6 | $5 | $5 | $6 |
| Gross Profit | $12 | $11 | $8 | $9 |
| % Margin | 67.4% | 69.9% | 63.5% | 61.6% |
| R&D Expenses | $0 | $8 | $4 | $10 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $17 | $39 | $26 | $27 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $1 | $1 | $0 |
| Operating Expenses | $19 | $48 | $31 | $37 |
| Operating Income | -$7 | -$36 | -$22 | -$27 |
| % Margin | -38.6% | -222.2% | -169.9% | -180.9% |
| Other Income/Exp. Net | $16 | $25 | -$2 | $1 |
| Pre-Tax Income | $9 | -$12 | -$25 | -$26 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $6 | $15 | -$11 | -$7 |
| % Margin | 33.2% | 94.4% | -80.6% | -44.7% |
| EPS | 0.13 | 0.5 | -0.48 | -0.37 |
| % Growth | -74% | 204.2% | -29.7% | – |
| EPS Diluted | 0.11 | 0.45 | -0.48 | -0.37 |
| Weighted Avg Shares Out | 27 | 27 | 26 | 20 |
| Weighted Avg Shares Out Dil | 33 | 30 | 26 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $1 |
| Interest Expense | $2 | $3 | $3 | $3 |
| Depreciation & Amortization | $1 | $1 | $1 | $2 |
| EBITDA | $12 | -$8 | -$21 | -$22 |
| % Margin | 70.5% | -51.3% | -159.8% | -144% |